skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Journal Of Clinical Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group
Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group

POPLIN, Elizabeth ; YANG FENG ; CELLA, David ; BENSON, Al Bowen ; BERLIN, Jordan ; ROTHENBERG, Mace L ; HOCHSTER, Howard ; MITCHELL, Edith ; ALBERTS, Steven ; O'DWYER, Peter ; HALLER, Daniel ; CATALANO, Paul

Journal of clinical oncology, 2009-08, Vol.27 (23), p.3778-3785 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
2
Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program
Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program
Material Type:
Artigo 		Adicionar ao Meu Espaço

Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program

Tandstad, Torgrim ; Dahl, Olav ; Cohn-Cedermark, Gabriella ; Cavallin-Stahl, Eva ; Stierner, Ulrika ; Solberg, Arne ; Langberg, Carl ; Bremnes, Roy M ; Laurell, Anna ; Wijkstrøm, Hans ; Klepp, Olbjørn

Journal of clinical oncology, 2009-05, Vol.27 (13), p.2122-2128 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
3
Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study
Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study

Wei, Andrew H ; Strickland, Jr, Stephen A ; Hou, Jing-Zhou ; Fiedler, Walter ; Lin, Tara L ; Walter, Roland B ; Enjeti, Anoop ; Tiong, Ing Soo ; Savona, Michael ; Lee, Sangmin ; Chyla, Brenda ; Popovic, Relja ; Salem, Ahmed Hamed ; Agarwal, Suresh ; Xu, Tu ; Fakouhi, Kaffa M ; Humerickhouse, Rod ; Hong, Wan-Jen ; Hayslip, John ; Roboz, Gail J

Journal of clinical oncology, 2019-05, Vol.37 (15), p.1277-1284 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
4
Response-Guided Induction Therapy in Pediatric Acute Myeloid Leukemia With Excellent Remission Rate
Response-Guided Induction Therapy in Pediatric Acute Myeloid Leukemia With Excellent Remission Rate
Material Type:
Artigo 		Adicionar ao Meu Espaço

Response-Guided Induction Therapy in Pediatric Acute Myeloid Leukemia With Excellent Remission Rate

ABRAHAMSSON, Jonas ; FORESTIER, Erik ; HELDRUP, Jesper ; JAHNUKAINEN, Kirsi ; JONSSON, Olafur G ; LAUSEN, Birgitte ; PALLE, Josefine ; ZELLER, Bernward ; HASLE, Henrik

Journal of clinical oncology, 2011-01, Vol.29 (3), p.310-315 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
5
Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma
Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma

Younes, Anas ; Sehn, Laurie H ; Johnson, Peter ; Zinzani, Pier Luigi ; Hong, Xiaonan ; Zhu, Jun ; Patti, Caterina ; Belada, David ; Samoilova, Olga ; Suh, Cheolwon ; Leppä, Sirpa ; Rai, Shinya ; Turgut, Mehmet ; Jurczak, Wojciech ; Cheung, Matthew C ; Gurion, Ronit ; Yeh, Su-Peng ; Lopez-Hernandez, Andres ; Dührsen, Ulrich ; Thieblemont, Catherine ; Chiattone, Carlos Sergio ; Balasubramanian, Sriram ; Carey, Jodi ; Liu, Grace ; Shreeve, S Martin ; Sun, Steven ; Zhuang, Sen Hong ; Vermeulen, Jessica ; Staudt, Louis M ; Wilson, Wyndham

Journal of clinical oncology, 2019-05, Vol.37 (15), p.1285-1295 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
6
Phase I/II Study of the Src Inhibitor Dasatinib in Combination With Erlotinib in Advanced Non–Small-Cell Lung Cancer
Phase I/II Study of the Src Inhibitor Dasatinib in Combination With Erlotinib in Advanced Non–Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I/II Study of the Src Inhibitor Dasatinib in Combination With Erlotinib in Advanced Non–Small-Cell Lung Cancer

HAURA, Eric B ; TANVETYANON, Tawee ; LANXI SONG ; RAWAL, Bhupendra ; SCHELL, Michael J ; BEPLER, Gerold ; CHIAPPORI, Alberto ; WILLIAMS, Charles ; SIMON, George ; ANTONIA, Scott ; GRAY, Jhanelle ; LITSCHAUER, Sharon ; TETTEH, Leticia ; NEUGER, Anthony

Journal of clinical oncology, 2010-03, Vol.28 (8), p.1387-1394 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
7
Trebananib (AMG 386) in Combination With Sunitinib in Patients With Metastatic Renal Cell Cancer: An Open-Label, Multicenter, Phase II Study
Trebananib (AMG 386) in Combination With Sunitinib in Patients With Metastatic Renal Cell Cancer: An Open-Label, Multicenter, Phase II Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Trebananib (AMG 386) in Combination With Sunitinib in Patients With Metastatic Renal Cell Cancer: An Open-Label, Multicenter, Phase II Study

Atkins, Michael B ; Gravis, Gwenaelle ; Drosik, Kazimierz ; Demkow, Tomasz ; Tomczak, Piotr ; Wong, Shirley S ; Michaelson, M Dror ; Choueiri, Toni K ; Wu, Benjamin ; Navale, Lynn ; Warner, Douglas ; Ravaud, Alain

Journal of clinical oncology, 2015-10, Vol.33 (30), p.3431-3438 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
8
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

SEQUIST, Lecia V ; YANG, James Chih-Hsin ; SU, Wu-Chou ; BENNOUNA, Jaafar ; KATO, Terufumi ; GORBUNOVA, Vera ; KI HYEONG LEE ; SHAH, Riyaz ; MASSEY, Dan ; ZAZULINA, Victoria ; SHAHIDI, Mehdi ; SCHULER, Martin ; YAMAMOTO, Nobuyuki ; O'BYRNE, Kenneth ; HIRSH, Vera ; MOK, Tony ; GEATER, Sarayut Lucien ; ORLOV, Sergey ; TSAI, Chun-Ming ; BOYER, Michael

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3327-3334 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
9
Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313
Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313

Ramanathan, Ramesh K ; McDonough, Shannon L ; Philip, Philip A ; Hingorani, Sunil R ; Lacy, Jill ; Kortmansky, Jeremy S ; Thumar, Jaykumar ; Chiorean, E Gabriela ; Shields, Anthony F ; Behl, Deepti ; Mehan, Paul T ; Gaur, Rakesh ; Seery, Tara ; Guthrie, Katherine A ; Hochster, Howard S

Journal of clinical oncology, 2019-05, Vol.37 (13), p.1062-1069 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
10
Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study
Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study

Kater, Arnon P ; Wu, Jenny Qun ; Kipps, Thomas ; Eichhorst, Barbara ; Hillmen, Peter ; D'Rozario, James ; Assouline, Sarit ; Owen, Carolyn ; Robak, Tadeusz ; de la Serna, Javier ; Jaeger, Ulrich ; Cartron, Guillaume ; Montillo, Marco ; Dubois, Julie ; Eldering, Eric ; Mellink, Clemens ; Van Der Kevie-Kersemaekers, Anne-Marie ; Kim, Su Young ; Chyla, Brenda ; Punnoose, Elizabeth ; Bolen, Christopher R ; Assaf, Zoe June ; Jiang, Yanwen ; Wang, Jue ; Lefebure, Marcus ; Boyer, Michelle ; Humphrey, Kathryn ; Seymour, John F

Journal of clinical oncology, 2020-12, Vol.38 (34), p.4042-4054 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2010  (532)
  2. 2010Até2012  (774)
  3. 2013Até2015  (647)
  4. 2016Até2019  (320)
  5. Após 2019  (374)
  6. Mais opções open sub menu

Idioma 

  1. Japonês  (464)
  2. Russo  (38)
  3. Norueguês  (2)
  4. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.